Bodmer Mark 4
4 · Evelo Biosciences, Inc. · Filed Jan 16, 2019
Insider Transaction Report
Form 4
Bodmer Mark
See Remarks
Transactions
- Award
Stock Option (Right to Buy)
2019-01-14+100,000→ 100,000 totalExercise: $13.71Exp: 2029-01-14→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]These options will vest as to 25% of the total grant on the first anniversary of the grant date with the remainder vesting in equal quarterly installments over a three-year period thereafter, subject to continued employment on such dates.